Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
285 | ANGPT2 | angiopoietin 2 | |
629 | CFB | complement factor B | |
1027 | CDKN1B | cyclin dependent kinase inhibitor 1B | |
1235 | CCR6 | C-C motif chemokine receptor 6 | |
1490 | CCN2 | cellular communication network factor 2 | |
1906 | EDN1 | endothelin 1 | |
2033 | EP300 | E1A binding protein p300 | |
2153 | F5 | coagulation factor V | |
2335 | FN1 | fibronectin 1 | |
3075 | CFH | complement factor H |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
11601 | Angpt2 | angiopoietin 2 | |
12458 | Ccr6 | C-C motif chemokine receptor 6 | |
12628 | Cfh | complement component factor h | |
14067 | F5 | coagulation factor V | |
14268 | Fn1 | fibronectin 1 | |
14962 | Cfb | complement factor B | |
17926 | Myoc | myocilin | |
18643 | Pfn1 | profilin 1 | |
18646 | Prf1 | perforin 1 (pore forming protein) | |
20296 | Ccl2 | C-C motif chemokine ligand 2 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
24770 | Ccl2 | C-C motif chemokine ligand 2 | |
24791 | Sparc | secreted protein acidic and cysteine rich | |
54258 | Cxcr1 | C-X-C motif chemokine receptor 1 | |
81523 | Myoc | myocilin | |
81810 | Tgfbr2 | transforming growth factor, beta receptor 2 | |
83571 | Cdkn1b | cyclin-dependent kinase inhibitor 1B | |
89805 | Angpt2 | angiopoietin 2 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
175781 | daf-4 | Cell surface receptor daf-4;Serine/threonine-protein kinase receptor;receptor protein serine/threonine kinase | |
176931 | ost-1 | Kazal-like domain-containing protein;SPARC | |
177668 | C49C8.5 | Fibrinogen C-terminal domain-containing protein | |
177911 | Y43C5A.2 | Fibrinogen C-terminal domain-containing protein | |
183582 | cof-2 | Olfactomedin-like domain-containing protein |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024